Is albumin infusion necessary after large volume paracentesis? Pro-main arguments

Liver International

Volumn 29, Issue 5, 2009, Pages 636-638

  Cárdenas, Andrés ^a   Ginès, Pere ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ARTICLE; ASCITES; BLOOD COMPONENT THERAPY; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEMODYNAMICS; HUMAN; HYPONATREMIA; ISCHEMIA; KIDNEY FAILURE; LIVER CIRRHOSIS; PARACENTESIS; PROGNOSIS; SURVIVAL RATE;

ALBUMINS; ASCITES; HUMANS; HYPOVOLEMIA; LIVER CIRRHOSIS; PARACENTESIS;

EID: 64749109609     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02027_1.x     Document Type: Article

References (24)

1. Cárdenas A, Ginès P. Mechanisms of ascites formation. In: Sanyal A, Shah V, eds. Portal Hypertension. Humana Press, Totowa, NJ, 2005; 65-84.
2. Ginès P, Arroyo V, Quintero E, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93: 234-41.
3. Salerno F, Badalamenti S, Incerti P, et al. Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients: A safe alternative therapy. J Hepatol 1987; 5: 102-8.
4. Moore KP, Wong F, Ginès P, et al. The management of ascites in cirrhosis: Report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-66.
5. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006; 55 (Suppl. 6): Vi1-12.
6. Ginès P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493-502.
7. Ruiz-del-Arbol L, Monescillo A, Jiménez W, et al. Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113: 579-86.
8. Ginès A, Fernández-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-110.
9. Sola-Vera J, Minana J, Ricart E, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003; 37: 1147-53.
10. Quinlan GJ, Martin GS, Evans TW. Albumin: Biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211-9.
11. Alderson P, Bunn F, Lefebvre C, et al. Albumin reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev, 8 October 2004;(4):CD001208.
12. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-56.
13. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 5: 403-9.
14. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008; 134: 1360-8.
15. Martín-Llahí M, Pépin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study. Gastroenterology 2008; 134: 1352-9.
16. Stadlbauer V, Mookerjee RP, Wright GA, et al. Albumin and other endotoxin removal methods restore neutrophil function ex vivo in patients with severe alcoholic hepatitis. Hepatology 2007; 46: 204A.
17. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
18. Planas R, Ginès P, Arroyo V, et al. Dextran 70 vs albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990; 99: 1736-44.
19. Salerno F, Badalamenti S, Lorenzano E, et al. Randomized comparative study of Hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13: 707-13.
20. Fassio E, Terg R, Landeira G, et al. Paracentesis with dextran 70 vs paracentesis with albumin in cirrhosis with tense ascites: Results of a randomized study. J Hepatol 1992; 14: 310-6.
21. Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol 1998; 10: 5-10.
22. Garcιa-Compean D, Zacarιas Villarreal J, Bahena Cuevas H, et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites. Liver 1993; 13: 233-8.
23. Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 2008; 299: 1166-78.
24. Runyon B. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-56.